Memantine and Antipsychotics Use

Clinical trial NCT00649220 · TERMINATED

Trial details

NCT number: NCT00649220
Sponsor: Merz Pharmaceuticals GmbH
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2008-07-01
Primary completion: 2009-05-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.